Labor Market Pulse · Life Sciences · October 2026
Life Sciences Labor Market Report: Iowa City, IA MSA — October 2026
Iowa City clinical and manufacturing pay outruns the national market.
Advertised CRA pay in Iowa City hit $121,250 against a $90,065 national median, while Johnson County unemployment held at 3.0%, signaling employers are paying up for scarce clinical and validation talent.
Free archive edition. Published by WageScape as sent to subscribers; data as of October 2026.
Key indicators
- Johnson County unemployment: 3.0% — vs 4.2% U.S. rate, Aug 2026
- CRA advertised pay, metro vs national: $121,250 — vs $90,065 national median
- Iowa City labor force: 102.5K (June 2026) — still below Feb 2026 peak of 103.9K
- National biopharma lab/R&D vacancy rate: 23.2% — Q1 2026, top 13 U.S. life sci markets
Key takeaways
CRA pay in Iowa City now outpaces the national rate.
Advertised median pay for Clinical Research Associates hit $121,250 locally against $90,065 nationally, reversing the usual coastal-premium pattern. That inversion suggests local employers are competing hard for a small pool of experienced CRAs, with demand concentrated at the experienced tier, consistent with national reports that CRA bottlenecks sit at that level.
Research Scientist pay is falling locally while climbing nationally.
Metro median dropped to $74,216 even as the national figure rose to $130,339 — a widening gap of roughly $56,000. Organizations benchmarking this role against national data risk under-pricing retention risk for scientists with mobility to larger biopharma hubs.
Validation Engineer demand signals a manufacturing talent squeeze.
Local advertised pay rose significantly to $121,331, surpassing the $106,478 national median. That premium tracks national signals of CDMOs competing hard for bioprocess and validation expertise, and may indicate Iowa City employers are paying up to avoid losing quality/manufacturing staff to outsourcing partners.
Regulatory Affairs pay strength cuts against a national softening.
Local advertised pay for Regulatory Affairs Specialists climbed to $103,011 while the national median edged down to $103,780, nearly converging. Given regulatory talent remains among the hardest national roles to fill, local employers holding pay firm may be defending against turnover ahead of chasing growth.
Median advertised pay by role — Iowa City, IA MSA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist | $69,669 | $74,216 | $90,603 | Moderate decline | $130,339 |
| Clinical Research Associate * | $62,098 | $121,250 | $128,750 | Significant increase | $90,065 |
| Lab Technician * | $38,917 | $44,670 | $47,927 | Moderate decline | $47,840 |
| Regulatory Affairs Specialist * | $88,842 | $103,011 | $109,084 | Significant increase | $103,780 |
| Clinical Data Manager | $74,125 | $74,125 | $74,125 | Significant decline | $123,653 |
| Biostatistician * | $91,938 | $124,129 | $146,223 | Stable | $131,958 |
| Validation Engineer * | $118,498 | $121,331 | $123,498 | Significant increase | $106,478 |
* State-level figure shown where metro postings were too few.
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Johnson County's 3.0% unemployment rate and a labor force that has yet to fully recover from its May 2026 dip signal a market with little slack for employers seeking credentialed scientific and regulatory talent. University of Iowa's outsized presence anchors local demand, while professional and scientific services employment losses statewide suggest Iowa City's specialist talent pool is shrinking even as national biopharma hiring activity rebounds.
What it means
Clinical Research Associate and Validation Engineer advertised pay are both up significantly locally, climbing well past prior levels and, in the CRA case, past the national median — a sign that Iowa City employers are bidding aggressively for a thin bench of experienced clinical and manufacturing-adjacent talent over entry-level candidates. With Research Scientist and Clinical Data Manager local pay falling even as national figures hold or rise, the metro risks losing competitiveness for R&D and data roles precisely as CRO/CDMO partners price in their own talent premiums. Consider reviewing whether build-vs-outsource models for clinical operations and data management still hold when local advertised pay for those functions is diverging from the national trend.
Looking ahead
Early indicator: Watch whether Johnson County's labor force, still below its February 2026 peak, recovers through year-end. A continued shortfall would tighten competition for lab and clinical talent further heading into 2027 headcount planning.
Emerging pressure point: Statewide professional, scientific and technical services job losses in September may foreshadow further R&D headcount strain in Iowa City if the pattern persists into Q4 state data releases.
Worth watching: National quit rate holding at 1.9% suggests experienced regulatory and clinical staff are staying put. Local employers planning 2027 growth roles should expect longer fill times and should not count on voluntary attrition to free up talent.
Potential inflection point: Local Clinical Data Manager pay has fallen sharply even as the role remains in demand nationally. A rebound or further decline next month will clarify whether this reflects a lasting local market shift or a temporary posting anomaly.
Sources
- Iowa Workforce Development / BLS LAUS — Johnson County unemployment rate at 3.0% in August 2026
- U.S. Bureau of Labor Statistics — Iowa City MSA labor force decline and partial recovery through mid-2026
- Industry life sciences workforce research — National CRA talent bottleneck concentrated at experienced tier
- Industry life sciences labor market report — Lab/R&D vacancy reached 23.2% across top 13 U.S. life sciences markets
- Bureau of Labor Statistics / industry survey — National quit rate holding at 1.9% across biopharma
- Iowa Workforce Development — Professional, scientific and technical services job losses statewide
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.